-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The 2021 ACR Annual Meeting was held hotly, and academic sharing continued
High blood pressure, hyperlipidemia, and high blood sugar are often referred to by us as the "three highs", which poses a great threat to human health.
High uric acid is closely related to gout.
Bone erosion is a common symptom of epidermal gout, which can lead to joint deformities and disability
Bone erosion is a common symptom of epidermal gout, which can lead to joint deformities and disability
In this two-year randomized controlled trial, 104 participants with bone erosion gout had oral uric acid-lowering therapy, and their serum urate ≥0.
Throughout the experiment, participants and researchers had unknown serum urate targets and serum urate results.
Primary and secondary endpoints
Primary and secondary endpointsFewer patients reached the randomized serum urate target value in the intensive group (53% in the intensive group vs 83% in the standard group at week 52; 62% vs 83% in the 104th week)
In general, it is difficult to achieve oral uric acid-lowering drugs in order to reduce serum urate below 0.
In general, it is difficult to achieve oral uric acid-lowering drugs in order to reduce serum urate below 0.
https://acrabstracts.
https://acrabstracts.
org/abstract/a-randomized-double-blind-controlled-trial-of-intensive-serum-urate-lowering-with-oral-urate-lowering-therapy-for-erosive-gout/#cancel
Leave a message here
